Copyright
©The Author(s) 2022.
World J Diabetes. Sep 15, 2022; 13(9): 752-764
Published online Sep 15, 2022. doi: 10.4239/wjd.v13.i9.752
Published online Sep 15, 2022. doi: 10.4239/wjd.v13.i9.752
Figure 5 Bza oxidation in adipose tissue of normoglycemic and STZ-induced diabetic mice: lack of influence of dietary Bza consumption.
Radiolabeled Bza was present at 0.1 mmol/L during 30 min incubation at 37°C with WAT homogenates from nondiabetic (white columns), nondiabetic Bza-drinking (red columns), STZ diabetic (yellow columns), STZ diabetic Bza-drinking (black columns). Mean ± SEM of eight determinations for nondiabetic mice and four determinations for lipoatrophic STZ diabetic mice. Different from nondiabetic at: aP < 0.02. No significant influence of Bza-treatment was detected. STZ: Streptozotocin; Bza: Benzylamine; WAT: White adipose tissues.
- Citation: Carpéné C, Stiliyanov Atanasov K, Les F, Mercader Barcelo J. Hyperglycemia and reduced adiposity of streptozotocin-induced diabetic mice are not alleviated by oral benzylamine supplementation. World J Diabetes 2022; 13(9): 752-764
- URL: https://www.wjgnet.com/1948-9358/full/v13/i9/752.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i9.752